CuraGen
Executive Summary
Exploiting technology from Yale and Cornell Universities, CuraGen Corp. is pursuing novel methods that may address the problem of isolating the genes and expressed proteins that are responsible for a number of complex disease states. Through its {Quantitative Expression Analysis} technique, Curagen can screen a sample of diseased tissue for the identity of the genes in the sample and the rate of those genes' expression.